|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:approves
|
gptkb:1991
|
|
gptkbp:availability
|
generic
|
|
gptkbp:brand
|
gptkb:Zoloft
gptkb:Prozac
|
|
gptkbp:class
|
selective serotonin reuptake inhibitors (SSR Is)
|
|
gptkbp:clinical_trial
|
Phase III
|
|
gptkbp:contraindication
|
liver disease
pregnancy
MAO inhibitors
|
|
gptkbp:dosage_form
|
gptkb:tablet
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:formulation
|
extended-release
immediate-release
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Handshake Drugs
|
|
gptkbp:ingredients
|
fluoxetine
sertraline
|
|
gptkbp:interacts_with
|
gptkb:beer
NSAI Ds
st. john's wort
|
|
gptkbp:invention
|
2025
|
|
gptkbp:is_used_for
|
treatment of depression
treatment of anxiety
|
|
gptkbp:legal_issue
|
prescription only
|
|
gptkbp:lifespan
|
24 hours
|
|
gptkbp:manager
|
oral
|
|
gptkbp:manufacturer
|
gptkb:Pharma_Corp
|
|
gptkbp:marketed_as
|
gptkb:drug
anxiolytic
|
|
gptkbp:packaging
|
blister pack
|
|
gptkbp:premiered_on
|
1 to 2 weeks
|
|
gptkbp:requires
|
gptkb:theorem
|
|
gptkbp:research_areas
|
mental health
pharmacology
clinical psychology
|
|
gptkbp:safety_features
|
gptkb:C
|
|
gptkbp:scholarships
|
do not stop abruptly
avoid driving until effects are known
monitor mood changes
|
|
gptkbp:side_effect
|
nausea
drowsiness
dry mouth
weight gain
suicidal thoughts
sexual dysfunction
serotonin syndrome
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:target_audience
|
gptkb:Person
adults
adolescents
|
|
gptkbp:bfsParent
|
gptkb:A_Ghost_Is_Born
|
|
gptkbp:bfsLayer
|
5
|